anmelden
FTSE All-Share
5.479,78
PKT
-90,59
PKT
-1,63
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu FTSE All-Share-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 13.11.20 | National Grid buy | Jefferies & Company Inc. | |
| 12.11.20 | National Grid Neutral | Goldman Sachs Group Inc. | |
| 11.11.20 | Diageo Outperform | Bernstein Research | |
| 11.11.20 | Diageo Hold | Kepler Cheuvreux | |
| 11.11.20 | Vodafone Group buy | UBS AG | |
| 11.11.20 | Diageo buy | Jefferies & Company Inc. | |
| 11.11.20 | Shell (ex Royal Dutch Shell) buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 10.11.20 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 10.11.20 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 10.11.20 | AstraZeneca Hold | Jefferies & Company Inc. | |
| 10.11.20 | London Stock Exchange (LSE) Outperform | Credit Suisse Group | |
| 10.11.20 | HSBC Underweight | JP Morgan Chase & Co. | |
| 10.11.20 | Barclays overweight | JP Morgan Chase & Co. | |
| 10.11.20 | Rio Tinto overweight | JP Morgan Chase & Co. | |
| 10.11.20 | Diageo Underweight | JP Morgan Chase & Co. | |
| 09.11.20 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 06.11.20 | AstraZeneca Outperform | Credit Suisse Group | |
| 05.11.20 | AstraZeneca Sell | UBS AG | |
| 05.11.20 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 05.11.20 | AstraZeneca Hold | Jefferies & Company Inc. | |
| 05.11.20 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 04.11.20 | HSBC buy | Goldman Sachs Group Inc. | |
| 04.11.20 | Barclays Neutral | Goldman Sachs Group Inc. | |
| 04.11.20 | BAT Outperform | Credit Suisse Group | |
| 03.11.20 | BAT buy | Goldman Sachs Group Inc. | |
| 03.11.20 | BP Outperform | Bernstein Research | |
| 03.11.20 | BP Equal-Weight | Morgan Stanley | |
| 03.11.20 | Shell (ex Royal Dutch Shell) overweight | Morgan Stanley | |
| 03.11.20 | National Grid overweight | JP Morgan Chase & Co. | |
| 03.11.20 | Prudential overweight | Barclays Capital | |
| 02.11.20 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 30.10.20 | Shell (ex Royal Dutch Shell) Outperform | Credit Suisse Group | |
| 30.10.20 | Shell (ex Royal Dutch Shell) Outperform | RBC Capital Markets | |
| 30.10.20 | GSK Underweight | Barclays Capital | |
| 30.10.20 | Shell (ex Royal Dutch Shell) Equal weight | Barclays Capital | |
| 30.10.20 | GSK buy | Goldman Sachs Group Inc. | |
| 30.10.20 | Lloyds Banking Group Outperform | RBC Capital Markets | |
| 29.10.20 | Lloyds Banking Group Sell | Goldman Sachs Group Inc. | |
| 29.10.20 | Lloyds Banking Group Neutral | JP Morgan Chase & Co. | |
| 29.10.20 | Shell (ex Royal Dutch Shell) Outperform | RBC Capital Markets |